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Abstract Peptides from the venom ducts of cone snails (genus 
Conus) contain y-carboxyglutamate residues. The y-glutamyl 
carboxylase responsible for this post-translational modification 
is localized in the microsomal fraction, strictly dependent on 
vitamin K, activated by ammonium sulfate, and is associated with 
endogenous substrate. The Km of the enzyme for vitamin K is 
comparable to that for the bovine carboxylase. However, a 
propeptide containing substrate related to the blood coagulation 
protein factor IX, a highly efficient substrate for the bovine 
enzyme, was poorly carboxylated by the Conus enzyme, 
suggesting differences in y-carboxylase recognition signal 
sequences and/or structural requirements at the carboxylation 
site. 
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1. Introduction 
A large and diverse group of biologically active small pep-
tides are found in the venom ducts of predatory cone snails 
(genus Conus). These peptides are the products of the normal 
transcription and translation machinery of the cell, but are 
notable for their very high frequency of post-translational 
modification (see for example [1]). One of the most unusual 
of these post-translational modifications is the carboxylation 
of glutamate (Glu) residues to y-carboxyglutamate (Gla), first 
described in peptides belonging to the conantokin family [2-
5]. The conantokins have been shown to be inhibitors of the 
NMDA (Af-methyl-D-aspartate) receptors. The occurrence of 
y-carboxyglutamate in other Conus peptides has also been 
established. 
The discovery of y-carboxylation of glutamate in the Conus 
venom duct system was completely unexpected because this 
modification had previously been described only in a small 
subset of mammalian proteins, which were either involved in 
the blood coagulation cascade, or in bone metabolism. More 
recently, another mammalian protein, gas6, related to the vi-
tamin K-dependent negative coregulator in the blood coagu-
lation cascade, has been identified and has been postulated to 
play a role in the control of cell growth [6] and tissue reor-
ganization [7]. This post-translational modification had not 
been described in any invertebrate system. To date, the Conus 
venom duct carboxylase system remains the only nonverte-
brate system where y-carboxylation of glutamate has been 
firmly established. 
While the mammalian carboxylase from bovine liver has 
been purified [8,9], cloned and sequenced [10,11], there is 
only one preliminary report on the Conus carboxylase in the 
literature [12], and the carboxylase activity in Conus venom 
ducts remains uncharacterized. The mammalian y-glutamyl 
carboxylase is believed to be an integral membrane protein 
that is found in the rough endoplasmic reticulum [13] and 
has a strict requirement for the reduced form of vitamin K 
as a cofactor [13]. All the known substrates for the mamma-
lian vitamin K-dependent carboxylase possess a highly con-
served propeptide sequence. Except in the case of the bone 
matrix Gla protein, this sequence is removed from the mature 
protein. This sequence is believed to be the primary binding 
site for the carboxylase and has been designated as the y-
carboxylation recognition site (y-CRS) [14]. 
The substrate routinely used for assaying the mammalian 
vitamin K-dependent carboxylase is the glutamate containing 
pentapeptide Phe-Leu-Glu-Glu-Leu (FLEEL) [15]. The 
FLEEL peptide has a millimolar Km for the carboxylase 
and its activity is stimulated by the addition of free propeptide 
[16-18]. It has been shown that Glu-containing peptides which 
have the propeptide sequence attached are high affinity sub-
strates for the carboxylase (Kn ~ 1(T6 M) [19,20]. A peptide 
expressed in E. coli (factor IX (FIX)—18—41), which consists 
of the propeptide and all normally carboxylated residues of 
the vitamin K-dependent clotting protein factor IX, is an ex-
cellent substrate for the bovine enzyme in in vitro carboxyla-
tion assays with an apparent sub-micromolar Km [21]. 
In this study, our aim has been to carry out an initial in-
vestigation of similarities and differences between the Conus 
venom duct carboxylase, and the mammalian enzyme system. 
For this purpose, we have used as the raw material the venom 
ducts of a fish-hunting Conus species, Conus radiatus. This 
species was chosen because its venom contains several pep-
tides which have a high content of y-carboxyglutamate. In-
cluded among these are a conantokin, conantokin-R which 
shows homology to previously characterized conantokins, 
and the recently characterized bromosleeper peptide [22]. 
The latter appears to be unrelated to the conantokin family 
but has a number of y-carboxyglutamate residues. The pres-
ence of Gla-rich peptides in Conus radiatus venom made it 
likely that the venom duct of this species had substantial 
carboxylase activity, an expectation confirmed in the results 
presented below. 
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2. Materials and methods 
2.1. Materials 
C. radiatus venom ducts were obtained from the Philippines. Apro-
tinin, pepstatin A, leupeptin, phenylmethylsulfonyl fluoride (PMSF), 
3-[(3-cholamidopropyl)dimethylammonio]-1 -propanesulfonate 
(CHAPS) and the pentapeptide FLEEL were purchased from Sigma. 
Protease inhibitors FFRCK and FPRCK were from Bachern; vitamin 
K, (phytonadione), from Abbot Laboratories, and NaH1 4C03 55 
mCi/mmol was from NEN. 
2.2. Preparation of microsomes 
C. radiatus ducts were frozen in liquid nitrogen and ground to a fine 
powder in a precooled mortar and pestle. This was then homogenized 
in buffer A, containing 25 mM MOPS pH 7.5, 500 mM NaCl and a 
mixture of protease inhibitors containing 2 mM DTT, 2 mM EDTA, 
0.125 ug/ml FFRCK, 0.125 ug/ml FPRCK, 0.5 ug/ml leupeptin, 0.7 
ug/ml pepstatin A, 34 ug/ml PMSF and 2 ug/ml aprotinin. The ho-
mogenate was centrifuged at 19000 rpm for 30 min at 4°C in a SS-34 
rotor in a Sorvall RC-5B centrifuge. The supernatant, designated low-
speed supernatant, was centrifuged in a TA 100.3 rotor at 75000 rpm 
for 60 min at 4°C in a Beckman TL 100 centrifuge. The pellet con-
taining microsomes was resuspended in buffer A, distributed in small 
aliquots, quick-frozen in liquid nitrogen and stored at —84°C. The 
low-speed supernatant, microsomal fraction and post-microsomal 
supernatant were assayed for carboxylase activity essentially as de-
scribed by Morris et al. [18]. 
2.3. Assay of carboxylase activity 
Bovine microsomes prepared according to Girardot [23] and snail 
microsomes were solubilized in 0.7% CHAPS/0.7% phosphatidyl chol-
ine/1.5 M NaCl for 20 min on ice. Final reactions were done in a total 
volume of 125 ul containing solubilized microsomes and a final con-
centration of reagents as follows: 25 mM MOPS, pH 7.4, 0.5 M 
NaCl, 0.2% CHAPS, 0.2% phosphatidyl choline, 0.8 M ammonium 
sulfate, 1.2 mM FLEEL, 5 uCi NaH14C03, 6 mM DTT, 222 uM 
reduced vitamin K (prepared as described by [24]). Reaction mixtures 
were incubated at 25°C for 30 min and were quenched by the addition 
of 75 ul of 1 N NaOH. 160 ul of the quenched reaction mixture was 
transferred to 1 ml of 5% trichloroacetic acid and boiled to remove 
unincorporated 14CÛ2. After cooling, 5 ml Ecolite (NEN) was added 
and the 1 4C02 incorporated determined in a Beckman LS 9800 coun-
ter. The amount of microsomal proteins present in the various experi-
ments are indicated in Results. All reported values are an average of 
three independent determinations. 
2.4. Determination of apparent ATm for reduced vitamin K 
Carboxylase activity was determined as described above except that 
reduced vitamin K concentration was varied to give a final concen-
tration from 0 to 400 uM. A total of 7 mg of bovine microsomal 
protein and 0.3 mg of snail venom duct microsomal proteins were 
used in the reactions. Kinetic parameters were determined using 
non-linear least squares analysis and fitting the data to the Michae-
lis-Menten equation. All reported kinetic values are averages of at 
least three independent assays. 
2.5. Assay for carboxylation of FIX—18-^41 
Carboxylase activity was determined essentially as described in Sec-
tion 2.3 with the following changes. A total of 7 mg of bovine micro-
somal protein and 0.3 mg of snail venom duct microsomal proteins 
were used in the reactions, ammonium sulfate was omitted and the 
concentration of the substrate, FIX—18—41, was varied between 0 and 
Table 1 
Fractionation of Conus radiatus venom duct carboxylase 
Fraction Total activity (nmol of 
incorporated in 30 min) 
Low-speed supernatant 32.8 
Microsome 44.2 
Post-microsomal supernatant 5.7 
In three independent microsome preparations the specific activity of the 
microsomal supernatant 0.4 ± 0.06. 
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Fig. 1. Effect of reduced vitamin K on carboxylation with bovine 
(open squares) and Conus (closed squares) microsomes. 
25 uM. Reactions were performed at 17°C for 9 h and processed as 
described above. 
2.6. Protein concentration 
Protein concentrations were determined by the micro assay using 
Bio-Rad protein assay reagents and bovine serum albumin as stand-
ard. 
3. Results 
3.1. Conus venom duct carboxylase, a microsomal fraction 
activity 
Crude extractions of C. radiatus venom ducts were exam-
ined for carboxylase activity as described by Morris et al. [18]. 
Carboxylase activity in the crude extract was fractionated into 
a microsomal fraction and a post-microsomal supernatant. 
The post-microsomal supernatant had less than 4% of the 
specific activity of the microsomal fraction, and the C. radia-
tus venom duct microsomal fraction had a 6-fold greater spe-
cific activity; essentially all carboxylase activity found in the 
crude extract is recovered in the microsomal fraction (Table 
1). This microsomal fraction was used for all subsequent ex-
periments. 
3.2. Conus carboxylase activity is vitamin K-dependent 
The carboxylase activity found in the microsomal fraction 
was assayed using the s tandard reaction mixture for the mam-
malian enzyme. As shown in Table 2, no carboxylase activity 
was detected in the absence of either microsomes or reduced 
vitamin K. These results demonstrate that the Conus carbox-
ylase is absolutely dependent on vitamin K, as previously 
established for the mammalian enzyme. 
The Km of the Conus enzyme for vitamin K is ~ 2-fold 
greater than that of the mammalian enzyme (28.9 ± 0.4 u M 
for the bovine enzyme and 57.2 ±4 .5 u M for the Conus en-
h Specific activity (nmol of 14CÛ2 
incorporated in 30 min per mg protein) 
4.2 
27.1 
1.0 
'-speed supernatant was 3.3 ± 1.3, microsomes 36.1 ± 18.0, and post-
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zyme), under conditions where the two activities are tested in 
parallel (see Fig. 1). Thus, the Conus carboxylase and the 
mammalian enzyme are very similar in their absolute require-
ment for vitamin K and in their affinity for the cofactor. 
3.3. Endogenous substrate in Conus carboxylase preparation 
and the effect of ammonium sulfate on carboxylase activity 
As shown in Table 2, the microsomal fraction apparently 
contains endogenous substrate. If the exogenous substrate 
peptide (the pentapeptide FLEEL) is omitted, a small but 
detectable carboxylase activity is observed. The Conus carbox-
ylase is greatly stimulated ( ~ 18-fold under these conditions) 
by the addition of these high levels of ammonium sulfate 
(Table 2) an effect also observed for the mammalian enzyme. 
Thus, for all of the parameters examined in the experiments in 
Table 2, the Conus venom duct carboxylase and the mamma-
lian enzyme appear to be similar. 
3.4. Specificity differences between the mammalian and the 
Conus venom duct enzymes 
In order to test whether the Conus enzyme recognizes the 
same signals that give the mammalian enzyme high affinity for 
certain substrates, a high affinity substrate for the mammalian 
enzyme was tested on both the mammalian enzyme and the 
Conus carboxylase. The propeptide-containing substrate for 
factor IX, comprised of amino acids —18-41, is a high affinity 
substrate for the bovine enzyme [8]. As shown in Fig. 2, 
although this peptide is an effective substrate for the mamma-
lian enzyme ( ^ m ~ 1.1 ±0.14 uM), under these experimental 
conditions no activity (above that seen in the absence of exog-
enous substrate) is observed for the Conus enzyme. 
4. Discussion 
The venom duct of Conus is the only invertebrate system in 
which carboxylation of glutamate to y-carboxyglutamate is 
known to occur. This modification is an unusual one and 
has only been characterized thus far in several proteins in 
the mammalian blood coagulation system, selected bone pro-
teins, and in Conus venom ducts. The expectation of this 
modification in the mammalian cell growth regulator gas6 
suggests that y-carboxylation may be more ubiquitous than 
previously thought. In the case of the Conus toxins, some of 
the Gla modifications are critical for biological activity. It was 
the goal of this study to characterize the y-carboxylation ac-
tivity of the Conus venom duct and compare its activity to the 
previously characterized mammalian vitamin K-dependent 
carboxylase. The comparison will also shed light on the evo-
lution of this enzymatic activity in phylogenetically disparate 
systems. 
Table 2 
Carboxylase activity of Conus radiatus microsomes 
pmol of 1 4C02 incorporated in 30 min 
Complete 
—microsomes 
—vitamin K 
—exogenous substrate 
- (NH 4 ) 2 S0 4 
455.16 ±9.73 
3.98 ±0.26 
3.84 ±0.26 
10.64 ±0.33 
25.63 ±3.54 
The complete reaction mixture contained microsomes (8 |lg protein), 
CHAPS, phosphatidylcholine, (NH4)2S04, FLEEL, NaH14C03 and 
reduced vitamin K at final concentrations described in Section 2. 
Experiments were done in triplicate. 
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Fig. 2. Carboxylation of the factor IX—18^ 4-1 peptide with bovine 
(open squares) and Conus (closed squares) microsomes. Identical re-
sults were obtained for another independent experiment. 
The enzyme activity characterized in the venom duct of the 
Conus radiatus exhibits striking similarities to its counterpart 
in mammals. The enzyme activity can be assayed by measur-
ing the incorporation of 14CC>2 into the pentapeptide substrate 
FLEEL which is based on a carboxylated sequence in several 
of the vitamin K-dependent blood clotting proteins. The 
Conus carboxylase activity is found to be enriched in the mi-
crosomal fraction of fractionated venom ducts. In order to 
achieve the same level of carboxylation of FLEEL, 10-20 
times as much bovine microsomal protein appears to be nec-
essary compared to that from Conus suggesting that the spe-
cific activity of the Conus enzyme at this stage of purification 
is 10-20 times higher than for the bovine enzyme. The Conus 
carboxylase also requires the reduced form of vitamin K for 
activity as is seen for the mammalian enzyme and possesses a 
similar apparent affinity for this essential cofactor. Finally the 
Conus enzyme is dramatically stimulated by ammonium sul-
fate as is the mammalian enzyme. 
A key feature of the mammalian carboxylase is its ability to 
recognize a highly conserved propeptide sequence present in 
all the known mammalian proteins which undergo y-carbox-
ylation. This y-carboxylation recognition signal is found N-
terminal to the glutamates that are carboxylated and then is 
removed to create the mature form of the protein. The only 
known exception to this motif is found in bone matrix Gla 
protein where the propeptide is present in the mature from of 
the protein [25,26]. The propeptide y-CRS is believed to be the 
primary binding site for the mammalian carboxylase and con-
fers a much higher affinity for the carboxylase to substrates 
which contain the CRS compared to glutamate containing 
substrates alone. 
We tested whether the Conus enzyme could recognize and 
carboxylate a high affinity 59-amino acid substrate which con-
tains the propeptide and carboxylated glutamates of the blood 
clotting protein factor IX. The Conus enzyme displays no 
activity above background for this substrate within the range 
of substrate concentrations tested. This suggests that this en-
zyme either does not recognize or poorly recognizes the mam-
malian y-CRS or that the glutamates present in mammalian 
substrate are not positioned appropriately so they can be 
modified by the Conus enzyme. This suggests that the Conus 
enzyme may possess a totally different motif for recognizing 
its native substrate. In addition, the invariant unit Glu-Xaa-
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Xaa-Xaa-Glu-Xaa-Cys, present in the Gla domains of all the 
mammalian proteins [26], is absent in the conantokins. 
The pattern of y-carboxylation of some of the Conus con-
antokin peptides may already provide a clue for the diverging 
substrate specificity of the two systems. In the 21-amino acid 
conantokin-T, only four of the six Glu residues are carboxyl-
ated [5]. The latter pattern of carboxylation seem to be more 
related to the vitamin K-dependent bone proteins where some 
glutamates are not carboxylated [25]. Although it is possible 
that even though the two enzymes are both vitamin K-de-
pendent and are able to carboxylate small glutamate-contain-
ing substrates, at the level of substrate specificity the two 
enzymes may have diverged significantly. Comparison of the 
propeptide sequences of the conantokins and conotoxins will 
be necessary in order to identify the Conus y-CRS. While a 
consensus amino acid sequence may emerge, the y-CRS may 
be a multitude of sequences defining a tertiary structure, as in 
the case of the signal peptides involved in protein transloca-
tion into the endoplasmic reticulum [27]. Studies to identify 
the CRS for the Conus enzyme are in progress. 
In conclusion, we have for the first time demonstrated that 
the y-carboxylase activity in the Conus venom duct is vitamin 
K-dependent and appears to posses many of the characteristic 
of the mammalian vitamin K-dependent carboxylase, but is 
unable to carboxylate a native mammalian substrate. The pu-
rification, cloning, and sequencing of the Conus vitamin K-
dependent carboxylase should permit a detailed comparison 
of its structural identity with the mammalian enzyme and 
suggest whether these enzymes are in fact related or whether 
unrelated proteins have converged upon a common function. 
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